CYCN — Cyclerion Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Cyclerion Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	54	13.4	7.57	3.23	3.24
Net Total Accounts Receivable
Net Total Receivables	0.1	0.096	0	0.556	1
Prepaid Expenses
Total Other Current Assets
Total Current Assets	55.5	14.8	8.02	4.22	4.63
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.47	1.22	0	0	0
Long Term Investments
Other Long Term Assets
Total Assets	59.3	18.1	13.4	9.57	9.98
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.1	7.63	2.09	0.725	0.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.1	7.63	2.09	0.725	0.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	48.2	10.5	11.3	8.85	9.09
Total Liabilities & Shareholders' Equity	59.3	18.1	13.4	9.57	9.98
Total Common Shares Outstanding
Total Preferred Shares Outstanding